We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Is Varenicline Effectiveness Declining in Randomized Trials?—Reply

Peter Hajek, PhD; Hayden McRobbie, MB, ChB, PhD; Katie Myers, MSc; John Stapleton, MSc; Al-Rehan Dhanji, MBBS, MRCS
Arch Intern Med. 2011;171(19):1770-1772. doi:10.1001/archinternmed.2011.494.
Text Size: A A A
Published online


In reply

Dhelaria and Rothberg point out the differences between success rates in our control group (standard varenicline regimen)1 compared with those in varenicline pivotal trials and trials in people with cardiovascular and chronic obstructive pulmonary disease. We have addressed this issue in our article.1 Comparisons across studies pose numerous problems especially if “success rate” means different things in different studies. The trials Dhelaria and Rothberg cite based their outcomes on no smoking between weeks 8 and 12, ie, over 4 weeks, while our abstinence rates are based on no smoking between the target quit date (TQD) and week 12, ie, over 12 weeks. The cited trials also had a large number of exclusion criteria, while ours had very few. In a comparable study from our clinic assessing continuous abstinence from TQD, the 4-week and 12-week abstinence rates in patients using different nicotine replacement products were 30.7% to 38.1% and 19.7% to 24.4% at 4 and 12 weeks, respectively.2 The abstinence rates in our control group of 33.3% and 20.8% at 4 and 12 weeks, respectively, are perhaps marginally low but not out of range. The results of the UK Stop Smoking Service, of which our clinic is a part, are another possible benchmark to compare our results with. The service does not report 12-week abstinence rates, but it has a carbon monoxide validated rate of abstinence between weeks 2 and 4 (ie, over 2 weeks) of 33.8%.3 The 33.3% rate of abstinence in our control group between TQD and week 4 (ie, over 4 weeks) is again within the expected range.



Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





October 24, 2011
Ranjit K. Dhelaria, MD, MRCP; Michael Rothberg, MD
Arch Intern Med. 2011;171(19):1770-1772. doi:10.1001/archinternmed.2011.493.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles